Literature DB >> 22899455

Improving the repeatability of heterochromatic flicker photometry for measurement of macular pigment optical density.

Olivia Howells1, Frank Eperjesi, Hannah Bartlett.   

Abstract

BACKGROUND: Heterochromatic flicker photometry (HFP) is a psychophysical technique used to measure macular pigment optical density (MPOD). We used the MPS 9000 (MPS) HFP device. Our aim was to determine if the repeatability of the MPS could be improved to make it more suitable for monitoring MPOD over time.
METHODS: Intra-session repeatability was assessed in 25 participants (aged 20-50 years). The resulting data was explored in detail, e.g., by examining the effect of removal and adjustment of data with less than optimal quality parameters. A protocol was developed for improved overall reliability, which was then tested in terms of inter-session repeatability in a separate group of 27 participants (aged 19-52 years).
RESULTS: Removal and adjustment of data reduced the intra-session coefficient of repeatability (CR) by 0.04, on average, and the mean individual standard deviation by 0.004. Raw data observation offered further insight into ways of improving repeatability. The proposed protocol resulted in an inter-session CR of 0.08.
CONCLUSIONS: Removal and adjustment of less than optimal data improved repeatability, and is therefore recommended. To further improve repeatability, in brief we propose that each patient perform each part of the test twice, and a third time where necessary (described in detail by the protocol). Doing so will make the MPS more useful in research and clinical settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899455     DOI: 10.1007/s00417-012-2127-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  32 in total

1.  Optical density spectra of the macular pigment in vivo and in vitro.

Authors:  R A Bone; J T Landrum; A Cains
Journal:  Vision Res       Date:  1992-01       Impact factor: 1.886

2.  Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.

Authors:  Eithne E Connolly; Stephen Beatty; David I Thurnham; James Loughman; Alan N Howard; Jim Stack; John M Nolan
Journal:  Curr Eye Res       Date:  2010-04       Impact factor: 2.424

3.  Measurement of macular pigment optical density using two different heterochromatic flicker photometers.

Authors:  Edward Loane; Jim Stack; Stephen Beatty; John M Nolan
Journal:  Curr Eye Res       Date:  2007-06       Impact factor: 2.424

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Dietary modification of human macular pigment density.

Authors:  B R Hammond; E J Johnson; R M Russell; N I Krinsky; K J Yeum; R B Edwards; D M Snodderly
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-08       Impact factor: 4.799

Review 6.  Risk factors for age-related maculopathy are associated with a relative lack of macular pigment.

Authors:  John M Nolan; Jim Stack; Orla O' Donovan; Edward Loane; Stephen Beatty
Journal:  Exp Eye Res       Date:  2006-11-01       Impact factor: 3.467

Review 7.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Authors:  S Beatty; H Koh; M Phil; D Henson; M Boulton
Journal:  Surv Ophthalmol       Date:  2000 Sep-Oct       Impact factor: 6.048

8.  Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys.

Authors:  Martha Neuringer; Marita M Sandstrom; Elizabeth J Johnson; D Max Snodderly
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

9.  Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid.

Authors:  Ana J Chucair; Nora P Rotstein; John Paul Sangiovanni; Alexandrine During; Emily Y Chew; Luis E Politi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

10.  Biological control of primate macular pigment. Biochemical and densitometric studies.

Authors:  G J Handelman; D M Snodderly; N I Krinsky; M D Russett; A J Adler
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-02       Impact factor: 4.799

View more
  6 in total

1.  Efficacy of Commercially Available Nutritional Supplements: Analysis of Serum Uptake, Macular Pigment Optical Density and Visual Functional Response.

Authors:  Richard A Bone; Pinakin Gunvant Davey; Betzabe O Roman; David W Evans
Journal:  Nutrients       Date:  2020-05-06       Impact factor: 5.717

Review 2.  Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration-Neurodegenerative Disease.

Authors:  Małgorzata Mrowicka; Jerzy Mrowicki; Ewa Kucharska; Ireneusz Majsterek
Journal:  Nutrients       Date:  2022-02-16       Impact factor: 5.717

Review 3.  Can Nutrition Play a Role in Ameliorating Digital Eye Strain?

Authors:  Drake W Lem; Dennis L Gierhart; Pinakin Gunvant Davey
Journal:  Nutrients       Date:  2022-09-27       Impact factor: 6.706

Review 4.  Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence.

Authors:  Drake W Lem; Dennis L Gierhart; Pinakin Gunvant Davey
Journal:  Nutrients       Date:  2021-06-06       Impact factor: 5.717

5.  Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance.

Authors:  Pinakin Gunvant Davey; Silverio D Alvarez; Jessica Y Lee
Journal:  Clin Ophthalmol       Date:  2016-08-29

6.  Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula.

Authors:  Pinakin Gunvant Davey; Thomas Henderson; Drake W Lem; Rebecca Weis; Stephanie Amonoo-Monney; David W Evans
Journal:  Nutrients       Date:  2020-10-26       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.